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Abstract
Objectives To develop imaging guidelines for patients with fistula-in-ano and other causes of anal sepsis.
Methods An expert group of 13 members of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) used
amodifiedDelphi process to vote on a series of consensus statements relating to the imaging of patients with potential anal sepsis.
Participants first completed a questionnaire to gather practice information and to help frame the statements posed.
Results In the first round of voting, the expert group scored 51 statements of which 45 (88%) achieved immediate consensus. The
remaining 6 statements were redrafted following input from the expert group and consensus achieved for all during a second
round of voting, including an additional statement drafted. No statement was rejected due to a lack of consensus. After redrafting
to improve clarity, 53 individual statements were presented.
Conclusion These expert consensus statements can be used to guide appropriate indication, acquisition, interpretation and
reporting of medical imaging for patients with potential fistula-in-ano and other causes of anal sepsis.
Key Points
•Medical imaging, notably magnetic resonance imaging, is used widely for the diagnosis and monitoring of fistula-in-ano and
other causes of anal and perianal sepsis.
•While the indexed medical literature is clear that diagnostic accuracy is potentially excellent, this depends on competent image
acquisition and interpretation.
• In order to facilitate this, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) has produced expert
consensus guidelines regarding the imaging of fistula-in-ano and related conditions.
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Abbreviations
CT Computed tomography
ESGAR European Society of Gastrointestinal and
Abdominal Radiology
EUA Examination under anaesthetic
MRI Magnetic resonance imaging
RAND/UCLA Research and Development/University of
California, Los Angeles
Introduction
Following a 2018 survey of its membership, the Research
Committee of the European Society of Gastrointestinal and
Abdominal Radiology (ESGAR) identified imaging of
fistula-in-ano as a priority for guideline development.
Prioritisation is contingent on the disease having considerable
clinical burden, having considerable impact on abdominal im-
aging services, existing uncertainty regarding best imaging
practice, and the existence of sufficient indexed research from
which to develop an evidence-based guideline. The target au-
dience for this guideline are radiologists interpreting medical
imaging for diagnosis of fistula-in-ano and other causes of
anal sepsis.
Methods
These guidelines were developed using a robust and transpar-
ent methodology via the ESGAR guideline development pro-
cess [1]. A “monodisciplinary” approach was adopted since
the guideline concerns radiological practice predominantly,
with a focus on technical aspects of image acquisition and
protocols, not requiring input from other societies. Ethical
permission was not required by the authors’ universities for
systematic review of available medical literature.
Guideline group selection
The ESGAR research committee appointed the guideline
Chair (SH), who then selected a Deputy (DT). The remaining
guideline authors (“expert group”) were then selected by the
Chair and his Deputy from the ESGAR membership follow-
ing a call for expressions of interest. Selection was influenced
by requirement for prior peer-reviewed indexed publication in
the field, combined with wide geographical representation.
Ultimately, there were 13 group members, including the
Chair and Deputy (and comprising the authorship of this
article).
Guideline development
Guideline development utilised a modified Delphi approach
based on the RAND/UCLA appropriateness criteria [2]. The
Chair produced a document detailing potential items for sub-
sequent consensus which were modified following discussion
with his Deputy. The Chair then performed a systematic liter-
ature search in order to establish the evidence base around
individual items. The US National Library of Medicine
PubMed journal citation database was searched on 26
July 2018 without date restriction using the string described
in Appendix 1, returning 1260 items. The review aimed to
identify diagnostic test accuracy studies that compared imag-
ing tests against each other and/or an independent reference
standard, in the clinical context of anal sepsis and/or related
conditions. Accordingly, there were 1121 exclusions as fol-
lows: topic not anal sepsis, etc., or where no imaging data was
reported (1021 exclusions); narrative review, guideline, com-
mentary, correspondence (70 exclusions); insufficient data re-
ported, defined as 10 or fewer subjects (e.g. case reports), and/
or no diagnostic accuracy data presented (29 exclusions); pa-
per could not be retrieved (1 exclusion). This left 139 research
papers (Appendix 2). These papers were then summarised in
an evidence table that presented the citation, the research ques-
tion, a brief summary of the findings, and the Oxford evidence
level [3]. This table was used as the basis to refine items for
subsequent consensus and identify new topics of concern. The
Chair and Deputy then developed a questionnaire that ad-
dressed these items via four broad groupings: experience with
pertinent imaging modalities and their clinical indications;
magnetic resonance (MR) imaging; anal endosonography;
study reporting. This questionnaire was completed indepen-
dently by all 13 expert group members (including the Chair
and Deputy).
Informed by responses, the Chair then reframed questions
as individual consensus statements that were posed to the
group for “first-round” voting via a PowerPoint presentation
(Microsoft Corporation). Each statement appeared on an indi-
vidual slide, with members asked to reflect their opinion of the
statement via one of five responses: “Disagree strongly”;
“Disagree somewhat”; “Undecided”; “Agree somewhat”;
“Agree strongly”. A free text option allowed members to ex-
press their reasoning. The Chair collated responses and de-
fined consensus for individual statements that achieved either
“Agree somewhat” or “Agree strongly” from at least 11 (i.e.
85%) members. Statements failing consensus were reframed
by the Chair accounting for free text responses, in an attempt
to incorporate members’ concerns. These reframed statements
were considered via a “second round”, in concert with the
evidence table. Members’ free text thinking around the prior
statements was also presented on the slides to help other mem-
bers understand why the original statement had failed to
achieve consensus (this procedure was used instead of a
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face-to-facemeeting, due to the wide international distribution
of the expert group).
Results
The lifetime experience of the expert group for interpreting
MR examinations for anal/perianal sepsis was 3 members,
100–499 examinations; 3 members, 500–999 examinations;
7 members, > 1000 examinations. The median number of
MR examinations reported annually by individual members
for anal/perianal sepsis was 100–199, with four members
reporting more than this. In contrast, it transpired that only 4
members performed and interpreted anal endosonography but
the Chair decided to proceed with voting on this, anticipating
that the statements may still prove useful to the readership.
Similarly, only two group members reported a lifetime inter-
pretation of 100 or more contrast examinations for anal/
perianal sepsis. Indeed, six members reported having no ex-
perience of contrast examinations.
In the first round, all group members considered 41 indi-
vidual statements (excluding 10 statements relating to anal
endosonography). Five (12%) of these failed to reach consen-
sus and were redrafted, after which consensus was achieved
for all. The 4 members performing anal endosonography con-
sidered 10 additional statements, one (10%) of which failed to
reach consensus; the redrafted statement achieved full consen-
sus. An additional statement relating to the definition of horse-
shoe extension was then posed to the group, and achieved
consensus. After collating second-round responses, the Chair
drafted the resulting guideline document, which comprised 53
individual statements (one original statement was split to fa-
cilitate interpretation). This was then reviewed and ultimately
approved by the expert group. The consensus statements, with
their associated evidence level, are shown in Table 1.
Discussion
As noted in the “Introduction”, the primary target audience for
this guideline are radiologists interpretingmedical imaging for
diagnosis of fistula-in-ano and other causes of anal sepsis. The
group anticipate that these guidelines can be implemented
rapidly in clinical practice since they predominantly describe
MRI techniques and interpretation practice that are already in
widespread clinical use. In particular, there is no specified
requirement for specialised equipment. Rather, this guideline
describes a “minimum dataset” for image acquisition and
reporting.
Using a modified Delphi approach, we achieved consensus
for 53 individual statements relating to imaging of potential
anal sepsis, notably fistula-in-ano. These guidelines cover 10
areas of interest. The first concerns clinical indications. While
this exercise was precipitated by a desire for guidelines around
imaging fistula-in-ano, it is clear that imaging, notablyMRI, is
appropriate to investigate several other pathologies that may
also cause anal sepsis. In some cases, differential diagnosis
between fistula-in-ano and another pathology (e.g. pilonidal
sinus) may be required, whereas in others imaging is highly
effective for diagnosis of life-threatening pathology, notably
necrotising fasciitis (where free tissue gas is especially well
demonstrated by CT). In Crohn’s disease, imaging can also be
used to direct and optimise treatment strategy and to monitor
the efficacy of this. Several research studies have been per-
formed that investigate the effect of imaging in the context of
potential anal sepsis, and evidence of benefit reached level II
standard (i.e. studies of consecutive patients compared with a
robust reference standard).
Concerning the modalities employed, there was a clear
preference for MRI. Several highly cited outcome studies of
consecutive patients imaged using MRI have been published,
confirming considerable diagnostic and therapeutic impact,
and providing level II evidence of benefit [4–6]. The group
encountered more difficulty when considering CT and con-
trast fistulography, which are now performed rarely by a large
majority of members. However, we did conclude that these
modal i t i e s have a ro le where MRI and/or ana l
endosonography is unavailable. In particular, group members
indicated that CT was sometimes performed for suspected
acute anal/perianal sepsis in emergency situations where
MRI was unavailable (e.g. overnight). We make no statement
regarding the level of experience required for competent in-
terpretation of these modalities since personal and research
evidence was lacking, in contrast to MRI [7].
Statements relating to patient preparation for anal MRI
were largely based on expert opinion since little research has
investigated this issue directly. In contrast, level III studies
have investigated MRI acquisition techniques. One of the
questions failing consensus initially was related to field
strength. The first-round statement indicated a preference for
3.0-T platforms but several group members felt that these
convey no additional diagnostic advantages over 1.5 T.
Ultimately, we agreed both 1.5-T and 3.0-T platforms are suf-
ficient for accurate diagnosis and choice will depend on local
availability and personal preference; many members indicated
no preference for either platform. The group agreed that axial
and coronal acquisitions should always be aligned with re-
spect to the anal axis since conventional acquisitions aligned
with the table top result in oblique anal images that frustrate
accurate diagnosis. These should always be combined with at
least one acquisition whose field-of-view is sufficient to cap-
ture distant extensions (for example, supra-levator, pre-sacral
disease). The questionnaire administered prior to the first
round of voting made it abundantly clear that a plethora of
different sequences were used across the group for daily clin-
ical practice. Nevertheless, the majority of group members
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Table 1 Final list of consensus statements agreed by more than 80% of
the committee members:
1. Clinical indications for imaging
• It is recommended that anal imaging (usually MRI) may be used to
investigate potential anal sepsis. Imaging can both diagnose and
classify fistula-in-ano. Imaging may also be used to investigate
acute ischioanal abscess (II)
• It is recommended that anal imaging (usually MRI) may be used to
investigate potentially complex pilonidal sinus and hidradenitis
suppurativa, where the differential diagnosis includes
cryptoglandular infection (III)
• It is recommended that anal imaging (usually MRI) may be used to
investigate anal pain in immunocompromised patients and anal
necrotising fasciitis, since imaging reveals whether sepsis is
present, and its extent (III)
• It is recommended that anal imaging (usually MRI) may be used to
monitor the effect of therapy on anal sepsis in Crohn’s disease (e.g.
biological/cellular/surgical). Imaging can also be used before
medical treatment is commenced, to identify any abscess that may
preclude biological therapy (II)
2. Imaging modalities
• MRI is recommended as the most clinically useful imaging
modality to investigate potential anal sepsis (II)
• It is not recommended to use CT scanning as the primary
investigation for fistula-in-ano where there is access to MRI
and/or anal US. However, CT is sometimes still performed
where MRI and/or anal US is unavailable, or in an emergency
setting. In such circumstances, CT may provide useful infor-
mation regarding the presence and extent of sepsis when
interpreted by experienced observers. Where performed, it is
recommended that CT employ intravenous contrast (V)
• It is not recommended to use contrast fistulography to investigate
fistula-in-ano where there is access to MRI and/or anal US.
However, fistulography is sometimes still performed where MRI
and/or anal US is unavailable. In such circumstances, fistulography
may provide useful information regarding the extent of sepsis when
interpreted by experienced observers who are aware of its limita-
tions (V)
3. Radiologist experience
• Competent interpretation of MRI to investigate fistula-in-ano re-
quires prior experience. On average, interpretation of at least 50
mentored examinations is recommended to achieve reasonable
competence for independent reporting (II)
4. Patient preparation for MRI
• It is not recommended that patients fast prior to MRI (V)
• It is not recommended that rectal emptying and/or distension is
used. An anal lumen marker (e.g. a catheter) is also not recom-
mended (V)
• It is not recommended that an intravenous smooth muscle relaxant
(e.g. hyoscine n butylbromide) is used (V)
• It is recommended that patients are scanned supine
• It is recommended that 0.1 mmol/kg gadolinium is sufficient,
where administered (V)
• It is recommended that no special modifications are necessary to
image children (V)
Table 1 (continued)
5. MRI acquisition technique
• It is recommended that field strengths of 1.5 T or 3 T may be used,
according to local availability and radiologist preference (V)
• It is recommended that a surface coil is used to enhance image
quality (III)
• It is not recommended that endoanal receiver coils are used because
they are unnecessary to achieve acceptable imaging quality (III)
• It is recommended that a minimal acceptable MRI examination for
fistula-in-ano should include axial, coronal and sagittal planes, with
the axial and coronal planes aligned to the anal canal axis (III)
• It is recommended that for at least one acquisition, the field of view
is sufficient to capture extensions remote from the primary track, to
include the supralevator and ischioanal compartments. This may be
achieved by using at least one acquisition with “whole-pelvis”
coverage (II)
6. MRI sequences
• MRI aims to identify sepsis and its precise relationship to the
sphincter complex and adjacent structures. Multiple different
sequences and orientations can be used to achieve this and will vary
according to the personal preferences of the radiologist and the
MRI platform(s) used (V)
• The planes and sequences considered mandatory by a majority of
committee members were axial, coronal and sagittal T2-weighted
(with or without fat suppression) (V)
•Many other sequences and orientations may be considered optional,
and used to further facilitate interpretation. For example, these may
include fat-suppressed T1-weighted sequences with gadolinium
enhancement, short T-1 inversion recovery (STIR) sequences and
diffusion-weighted sequences (V)
7. Examination timing
• It is recommended that MRI is acquired 4 weeks or more after
therapeutic examination under anaesthetic (EUA). Interpretation of
MR imaging following surgical intervention is challenging because
of difficulties distinguishing between cavities created by surgical
drainage and extensions that have not been treated (V)
8. Interpretation and reporting
• It is recommended that the radiological report include the clinical
details (V)
• It is recommended that the radiological report include the Parks
classification for any fistula identified (V)
• It is recommended that the radiological report include the St. James
classification if used locally and believed useful, but not at the
expense of the Parks classification (V)
• It is recommended that the total number of fistulas is stated where
multiple fistulas are present. Each individual fistula should then be
described in turn as per these guidelines (V)
• It is recommended that the exact radial location of any fistula is
identified using the “clock face” nomenclature. Fistula location
may also be described with reference to the appropriate anal
quadrant, but not at the expense of an exact description (V)
• It is recommended that the exact radial location of the internal
opening is identified using the “clock face” nomenclature.
Location can also be described with reference to the
appropriate anal quadrant, but not at the expense of an exact
description (V)
• It is recommended that the exact radial location of the external
opening is identified using the “clock face” nomenclature. Location
can also be described with reference to the appropriate anal
quadrant, but not at the expense of an exact description (V)
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adopted T2-weighted sequences (with or without fat suppres-
sion) in axial, coronal and sagittal orientations. We were able
to reach consensus by adopting a statement that recommended
any sequence able to “identify sepsis and its precise relation-
ship to the sphincter complex and adjacent structures”.
One issue familiar to practitioners is the difficulty encoun-
tered when MRI is performed soon after therapeutic examina-
tion under anaesthetic (EUA), when it can be problematic
differentiating between treated and untreated disease.Wewere
unable to identify any indexed research study that addressed
this issue directly, so the recommendation that post-EUAMRI
be delayed until at least 4 weeks was based on expert opinion
alone.
The group was also able to reach consensus regarding a
“minimum dataset” of information that should be contained
within the imaging report, although these were based exclu-
sively on expert opinion since we identified no research that
investigated these items directly. However, a research article
published by a group member subsequent to our literature
search found that structured imaging reports for patients with
fistula-in-anomissed fewer key features than narrative reports,
Table 1 (continued)
• It is recommended that the height of the internal opening should be
described relative to adjacent structures (e.g. presumed level of
dentate line, puborectalis, anal verge). An exact measurement (in
mm) may also be provided if possible, but not at the expense of a
relative description (V)
• Occasionally a single primary fistula track may have multiple
internal openings. Where this is the case, it is recommended that
this fact is stated along with the number and location of internal
openings. The same applies to multiple external openings (V)
• Occasionally multiple fistula tracks may share a single internal
opening. Where this is the case, it is recommended that this fact is
stated along with the location of the internal opening. The same
applies to shared external openings (V)
• The length of the fistula may be reported if this can be measured
with reasonable precision, but is optional and not mandatory (V)
• It is recommended that whether a fistula contains a seton is reported
(noting that setons are occasionally difficult to identify with
certainty) (V)
• It is recommended that the anatomical location of any
extension(s) identified is reported, irrespective of whether it is
inter-sphincteric, ischio-anal, supralevator, or in any other
anatomical location (V)
• In addition to reporting the anatomical location of any extension(s)
identified, it is recommended that an indication of the size should
be given. Since the morphology of extensions is variable and true
volume measurement is difficult, maximal cavity diameter is often
used to reflect size (V)
• It is recommended that a “horseshoe” extension is defined
radiologically as a semilunar region of sepsis that spreads in the
horizontal plane either side of an internal opening, to involve two or
more adjacent quadrants. Horseshoe extensions may be ischioanal,
intersphincteric, or supralevator (V)
• It is not recommended to describe individually all of those
anatomical compartments that are free of disease. However, a
general summary covering regions free of disease can be included if
wished (V)
• It is recommended to report less common findings when
encountered. Such findings might include proctitis or sacral
osteomyelitis, for example (V)
• It is recommended that comment is made regarding the anatomical
integrity of the external and internal sphincters, especially where
there is evidence of sphincter disruption (perhaps contingent on
prior fistula surgery) (V)
• It is recommended that the report reference any prior MR imaging
where this is available, and that it describes how the present
examination relates to these (V)
9. Recent developments
• Fistula activity may be reflected by various imaging biomarkers,
including MR T2 signal intensity and/or enhancement following
gadolinium contrast. Assessment of activity is relatively novel and
criteria for “active” vs. “inactive” disease need precise definition.
Accordingly, while it is not mandatory to report fistula “activity”, it
is recommended that this information is provided where deemed
useful by the radiologist and/or referring clinicians (III)
10. Anal endosonography
• Competent interpretation of anal endosonography to investigate
fistula-in-ano requires prior experience. On average, interpretation
of at least 50 mentored examinations is recommended to achieve
reasonable competence for independent performance and reporting
(V)
Table 1 (continued)
• It is recommended that patients require no special preparation and
are usually examined in the left-lateral position. The prone position
is an alternative (III)
• Instillation of hydrogen peroxide into the fistula is not
recommended
•Generally, most patients tolerate the examination well and sedation/
analgesia is not recommended (V)
• It is recommended that a 360° axial endoprobe between 7 and
10 MHz is used. A convex endoanal axial probe (e.g. for prostatic
imaging) can be used where a full 360° probe is unavailable (V)
• 3D image acquisition is not recommended as it is unnecessary to
achieve maximal diagnostic accuracy. However, it can be helpful
where it is necessary to review the examination subsequently (V)
• It is recommended that simple grey-scale imaging is sufficient for
optimal diagnostic accuracy (V)
• Children are a special case and it is recommended that practitioners
be especially sensitive regarding the intimate and potentially
distressing nature of the examination. It is recommended that
practitioners provide as reassuring an environment as possible. In
young children, who may not be able to cooperate, general
anaesthesia may be considered to facilitate the examination (V)
• In the context of fistula-in-ano, anal endosonography is usually
deployed to answer specific clinical questions. It is recommended
that MRI is the primary modality with which to image fistula-in-
ano (II)
• Given this, it is recommended that anal US is used where MRI is
contraindicated, to image the internal opening with greater spatial
resolution than MRI, and to assess prior or anticipated sphincter
division (V)
Evidence strength (Oxford Centre for Evidence Based medicine; refer-
ence [3]) shown in parentheses: V, expert opinion; IV, case control studies;
III, inconsistent reference standard; II, cohort study with consistent ref-
erence standard; I, systematic review of level II studies
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and had greater utility for the referring clinician [8]. A further
article from another group member advised a minimum
dataset of items necessary for an informative report [9].
Accordingly, Table 2 describes those items that the present
group considered comprise a minimum dataset for the
reporting of MRI for fistula-in-ano. The aim is to present
imaging information in a format useful to the referring clini-
cian. For this reason, the group emphasised the importance of
Parks’ classification [10] and clock-face nomenclature since
these are concepts instantly familiar to clinicians and radiolo-
gists working in this field. The group decided that the exact
radial location of any fistula should be reported, preferring this
to the appropriate quadrant (although the latter can be includ-
ed if wished). It should be noted that fistula tracks often follow
a very tortuous route so that the internal and external openings
may not be in the same quadrant, and the reporting radiologist
may have to settle on an approximation for the location of the
primary track overall. The fact that the group recommend the
radial location of both internal and external openings be re-
ported should account for this.
The internal opening of most fistulas is at the dentate level,
which is where the anal glands tend to congregate, emptying
into the anal crypts, and these glands are believed to be the
source of cryptoglandular sepsis [10]. The dentate line is a
critical landmark and the radiological report should indicate
the level of the internal opening relative to this (especially if
higher). However, the problem is that the dentate line marks a
histological boundary invisible on conventional imaging (the
transition of modified columnar epithelium to squamous).
Furthermore, anal canal length varies from person-to-person
and is generally shorter in women. In general, the dentate line
can be found approximately one-third along the anal canal
length, cranial to the external anal verge. Inexperienced ob-
servers frequently estimate dentate level as higher than the real
level. While acknowledging that no method is precise, for
guidance, we suggest it is reasonable to estimate dentate line
level relative to other structures: Methods might include mea-
suring a distance between 1 to 2 cm cranial to the anal verge or
by identifying the anal canal level a little caudal to the lower-
most fibres of the puborectalis muscle. Some members pro-
vide the distance between the internal opening and the most
caudal extent of the subcutaneous external sphincter (by mea-
surement on coronal acquisitions).
The group encountered some difficulty when it came to
indicating the size of any extension encountered since their
morphology is variable. While volume measurements may
circumvent this, volume is used rarely in daily clinical practice
and is less familiar to surgeons. Ultimately, we settled on
maximal diameter as the best compromise. This issue is sim-
ilar to the distinction between an “abscess” and a “track / tract”
because there is no generally accepted definition that differ-
entiates between the two. Ultimately, accurate identification
and location of sepsis is more important than the precise term
used to describe it. There was also some discussion as to
whether the maximal diameter of an extension should be re-
stricted to its cavity or include any fibrous wall. Members
decided that cavity measurement best reflected the need for
treatment, e.g. surgical drainage.
First-round consensus failed for a statement regarding fis-
tula “activity”. A number of recent publications have consid-
ered activity, notably in patients with Crohn’s fistulas [11–13].
The concept of activity is well established for enteric Crohn’s
disease and when applied to fistula-in-ano is defined as in-
flammatory activity within the fistula reflected, for example,
by T2 hyperintensity and/or enhancement following gadolin-
ium contrast. While authors of these articles considered the
topic important, other group members reported that their
surgeons/gastroenterologists did not find this concept useful,
being more concerned with whether a fistula was present or
not, and its morphology. Ultimately, the group achieved con-
sensus by recommending that activity be reported where local
clinicians find the information helpful.
As noted earlier, it transpired that only four of the expert
group performed anal endosonography but we nevertheless
pressed ahead with consensus statements on this, believing
some information to be preferable to no information at all.
Table 2 Minimum dataset for the
MRI reporting of fistula-in-ano Item
1. Clinical details State the clinical question being asked of the radiologist.
2. Fistula State whether a fistula is present or not (or sinus, or isolated abscess, etc.); its radial
location (clock-face); its Parks classification; radial location and level of internal
opening; radial location of external opening. Repeat for multiple fistulas.
Describe shared internal/external openings, etc. State if seton present. Describe
activity if used locally.
3. Extensions State whether an extension(s) is present or not and its anatomical location. Indicate
the maximal cavity diameter.
4. Sphincter integrity Comment on internal and external sphincter integrity.
5. Associated findings e.g., Proctitis, osteomyelitis
6. Comparison with prior
imaging
Describe how imaging relates to prior studies where available.
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Ultimately, consensus was achieved for 10 statements, most of
which were based on expert opinion alone, and which con-
cluded that, overall, MRI is the preferred modality with which
to image fistula-in-ano. Endosonography will have a specific
role to image the internal opening with greater spatial resolu-
tion than MRI, and to assess prior or anticipated sphincter
division. It is interesting to note that group opinion diverged
from the indexed literature in places. This was most notable
for hydrogen peroxide instillation: We identified 19 indexed
articles describing hydrogen peroxide. Nine of these com-
pared enhanced and unenhanced endosonography, with 7
finding enhancement beneficial. However, none of the group
considered this adjunct necessary for accurate diagnosis.
Similarly, none of the group used perineal US, presumably,
because they have access to endosonography.
Concerning future research, since pre-operative classifica-
tion of fistula-in-ano and similar pathology by imaging is al-
ready excellent, further gains in diagnostic accuracy are likely
to be limited. Our consensus suggests that future research is
likely to centre on the clinical utility of “activity” in the con-
text of Crohn’s disease. These guidelines will be updated by
ESGAR to account for these and other related developments.
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References
1. Plumb AAO, Lambregts D, Bellini D, Stoker J, Taylor S, ESGAR
Research Committee (2019) Making useful clinical guidelines: the
ESGAR perspective. Eur Radiol 29:3757–3760
2. Fitch K, Bernstein SJ, Aguilar MD et al (2001) The RAND/UCLA
appropriateness method user’s manual. RAND Corporation, Santa
Monica
3. Howick J, Chalmers I, Glasziou P et al (2011) The 2011 Oxford
CEBM evidence levels of evidence (introductory document).
Oxford Centre for Evidence Based Medicine. Available via http://
www.cebm.net/index.aspx?o=5653. Accessed 26 Mar 2020
4. Lunniss PJ, Armstrong P, Barker PG, Reznek RH, Phillips RK
(1992) Magnetic resonance imaging of anal fistulae. Lancet 340:
394–396
5. Buchanan G, Halligan S, Williams A et al (2002) Effect of MRI on
clinical outcome of recurrent fistula-in-ano. Lancet 360:1661–1662
6. Chapple KS, Spencer JA, Windsor AC, Wilson D, Ward J,
Ambrose NS (2000) Prognostic value of magnetic resonance im-
aging in the management of fistula-in-ano. Dis Colon Rectum 43:
511–516
7. Buchanan GN,Halligan S, Taylor S,WilliamsA, CohenR, Bartram
C (2004) MRI of fistula in ano: inter- and intraobserver agreement
and effects of directed education. AJR Am J Roentgenol 183:135–
140
8. Tuncyurek O, Garces-Descovich A, Jaramillo-Cardoso A et al
(2019) Structured versus narrative reporting of pelvic MRI in
perianal fistulizing disease: impact on clarity, completeness, and
surgical planning. Abdom Radiol (NY) 44:811–820
9. Ho E, Rickard M, Suen M et al (2019) Perianal sepsis: surgical
perspective and practical MRI reporting for radiologists. Abdom
Radiol (NY) 44:1744–1755
10. Parks AG, Gordon PH, Hardcastle JD (1976) A classification of
fistula-in-ano. Br J Surg 63:1–12
11. Ziech ML, Lavini C, Bipat S et al (2013) Dynamic contrast-
enhancedMRI in determining disease activity in perianal fistulizing
Crohn disease: a pilot study. AJR Am J Roentgenol 200:W170–
W177
12. Horsthuis K, Ziech ML, Bipat S et al (2011) Evaluation of anMRI-
based score of disease activity in perianal fistulizing Crohn’s dis-
ease. Clin Imaging 35:360–365
13. Hindryckx P, Jairath V, Zou G et al (2019) Development and vali-
dation of a magnetic resonance index for assessing fistulas in pa-
tients with Crohn’s disease. Gastroenterology 157:1233–1244
e1235
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
4740 Eur Radiol  (2020) 30:4734–4740
